Description
Sofokem, also known internationally as Sovaldi, is a pharmaceutical formulation meticulously crafted by Cytomed, a division of Alkem Laboratories Ltd., to address the challenges posed by Hepatitis C virus (HCV) infection. Each pack contains 28 tablets, with each tablet containing 400 mg of Sofosbuvir, the potent antiviral agent crucial in HCV treatment.
Key Features:
- Active Ingredient: Sofokem contains Sofosbuvir, a breakthrough direct-acting antiviral (DAA) agent that specifically targets the Hepatitis C virus, disrupting its replication cycle and aiding in the eradication of the virus from the body.
- Brand Recognition: Sofokem is globally recognized under the trade name Sovaldi, renowned for its efficacy and safety in the treatment of chronic HCV infection. Its formulation as Sofokem ensures accessibility to patients worldwide.
- Manufactured by Cytomed (Alkem Laboratories Ltd.): Sofokem is manufactured by Cytomed, a division of Alkem Laboratories Ltd., a leading pharmaceutical company known for its commitment to quality, innovation, and affordability in healthcare. Cytomed employs state-of-the-art manufacturing facilities and rigorous quality control measures to ensure the highest standards of pharmaceutical products.
Indications:
- Sofokem is indicated for the treatment of chronic Hepatitis C virus (HCV) infection in adults, either in combination with other antiviral agents or as a standalone therapy, depending on the genotype of the virus and the patient’s medical history.
Dosage and Administration:
- The recommended dosage of Sofokem varies depending on factors such as the patient’s HCV genotype, liver function, and prior treatment history.
- Sofokem is typically administered orally as a single daily dose, with or without food.
- Dosage adjustments may be necessary in patients with renal impairment or other medical conditions. Consultation with a healthcare provider is essential for personalized dosing recommendations.
Storage Information:
- Store Sofokem tablets at room temperature (20°C to 25°C), away from moisture and direct sunlight.
- Keep the tablets in their original packaging to protect them from degradation.
- Keep Sofokem out of reach of children and pets.
Precautions and Warnings:
- Sofokem should be used under the supervision of a qualified healthcare professional experienced in the treatment of chronic HCV infection.
- Prior to initiating Sofokem therapy, screening for Hepatitis B virus (HBV) infection is recommended, as reactivation of HBV can occur during treatment.
- Patients should be monitored regularly for liver function tests and adverse reactions during Sofokem therapy.
Disclaimer:
- Sofokem 400 mg Tablet 28’s is a prescription medication intended for the treatment of chronic Hepatitis C virus (HCV) infection. Patients should consult their healthcare provider for proper diagnosis and treatment recommendations.
- This product description provides general information about Sofokem and is not intended to replace medical advice. Patients should seek guidance from their healthcare provider regarding their specific medical condition and treatment options.
Reviews
There are no reviews yet.